David Grieve
Impact in
-
- Cardiac Fibrosis and Remodeling
- Cardiovascular Function and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Renin-Angiotensin System Studies
- Physiology top 1%
- Nitric Oxide and Endothelin Effects
Papers in
-
- Cardiac Fibrosis and Remodeling 28
- Cardiovascular Function and Risk Factors 8
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Physiology 32
- Nitric Oxide and Endothelin Effects 31
- Co-authors
- Ajay M. Shah (28 shared papers)Alison C. Cave (20 shared papers)Jian‐Mei Li (3 shared papers)Alison C. Brewer (5 shared papers)Brian D. Green (11 shared papers)Robin Ray (2 shared papers)Nicholas P. Gall (2 shared papers)Jonathan Byrne (4 shared papers)
- Journals
- British Journal of Pharmacology (7 papers)Cardiovascular Drugs and Therapy (7 papers)Stem Cells (4 papers)Atherosclerosis (3 papers)Journal of Molecular and Cellular Cardiology (3 papers)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
David Grieve
99 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 104
- Cardiology and Cardiovascular Medicine 2k
- Physiology 1.6k
- Endocrinology, Diabetes and Metabolism 534
- Biochemistry 221
- Molecular Biology 1.6k
Countries citing papers authored by David Grieve
This map shows the geographic impact of David Grieve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Grieve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Grieve more than expected).
Fields of papers citing papers by David Grieve
This network shows the impact of papers produced by David Grieve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Grieve. The network helps show where David Grieve may publish in the future.
Co-authors
The 25 scholars most cited alongside David Grieve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 540 | |
| 2 | 2002 | 450 | |
| 3 | 2010 | 395 | |
| 4 | 2003 | 358 | |
| 5 | 2011 | 282 | |
| 6 | 2006 | 267 | |
| 7 | 2008 | 229 | |
| 8 | 2010 | 222 | |
| 9 | 2014 | 177 | |
| 10 | 2017 | 160 | |
| 11 | 2017 | 150 | |
| 12 | 2020 | 138 | |
| 13 | 2008 | 136 | |
| 14 | 2006 | 130 | |
| 15 | 2009 | 116 | |
| 16 | 2009 | 111 | |
| 17 | 2001 | 109 | |
| 18 | 2004 | 93 | |
| 19 | 2005 | 93 | |
| 20 | 2015 | 92 |
About David Grieve
David Grieve is a scholar working on Cardiology and Cardiovascular Medicine, Physiology, Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems and Molecular Biology, having authored 101 papers that have together received 5.8k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (31 papers), Cardiac Fibrosis and Remodeling (28 papers), Diabetes Treatment and Management (10 papers), Cardiovascular Function and Risk Factors (8 papers), Angiogenesis and VEGF in Cancer (8 papers), Regulation of Appetite and Obesity (7 papers), Redox biology and oxidative stress (6 papers) and Chemotherapy-induced cardiotoxicity and mitigation (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2k citations), Physiology (1.6k citations), Endocrinology, Diabetes and Metabolism (534 citations), Biochemistry (221 citations) and Molecular Biology (1.6k citations). David Grieve has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Ajay M. Shah, Alison C. Cave, Jian‐Mei Li, Alison C. Brewer, Brian D. Green, Robin Ray, Nicholas P. Gall, Jonathan Byrne, Min Zhang and Narayana Panicker Anilkumar. Their work appears in journals such as British Journal of Pharmacology, Cardiovascular Drugs and Therapy, Stem Cells, Atherosclerosis and Journal of Molecular and Cellular Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.